IPCA Laboratories
Gangaprasad Kharate is an experienced professional in the clinical research and pharmaceutical sectors, currently serving as Manager of Clinical Research at Ipca Laboratories Limited since December 2023. Prior to this role, Gangaprasad held the position of Project Manager at Veeda Clinical Research from November 2021 to December 2023 and worked at Wockhardt Ltd. for over thirteen years in various capacities, including Project Management and Research Scientist. Gangaprasad's career began as a Clinical Research Associate at Anazeal Research Pvt. Ltd. and included a role as Production Officer at Ajanta Pharma Ltd. Gangaprasad Kharate holds a Master of Pharmacy in Pharmacology from SVKM's Narsee Monjee Institute of Management Studies and a Bachelor of Pharmacy from Nanded Pharmacy College in Maharashtra, India.
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.